{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:10:42Z","timestamp":1787026242214,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Plasmalogens have been shown to improve neurodegenerative pathology and cognitive function. We hypothesized that plasmalogens work in small amounts as a kind of hormone interacting with a G protein-coupled receptor, and then explored the effects of scallop-derived purified plasmalogens on psychobehavioral conditions in a randomized placebo-controlled trial of college athletes in Japan.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods and materials:<\/jats:bold>\n                    Eligible participants were male students aged 18\u201322\u00a0years who belonged to university athletic clubs. They were randomly allocated to either plasmalogen (2\u00a0mg per day) or placebo treatment of 4\u00a0weeks\u2019 duration. The primary outcome was the T-score of the Profile of Mood States (POMS) 2\u2013Adult Short, and the secondary outcomes included the seven individual scales of the POMS 2, other psychobehavioral measures, physical performance, and laboratory measurements. The trial was registered at the Japan Registry of Clinical Trials (jRCTs071190028).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Forty participants (20 in the plasmalogen group and 20 in the placebo group) completed the 4-week treatment. The Total Mood Disturbance (TMD) score of the plasmalogen group showed a greater decrease at 4 weeks than that of the placebo group while the between-group difference was marginally significant (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.07). The anger-hostility and fatigue-inertia scores of the POMS 2 decreased significantly in the plasmalogen group, but not in the placebo group, at 4\u00a0weeks. Between-group differences in those scores were highly significant (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.003 for anger-hostility and\n                    <jats:italic>p<\/jats:italic>\n                    = 0.005 for fatigue-inertia). The plasmalogen group showed a slight decrease in the Athens Insomnia Scale at 2\u00a0weeks, and the between-group difference was near-significant (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.07). The elapsed time in minute patterns on the Uchida-Kraepelin test, which is a marker of mental concentration, revealed significantly greater performance in the plasmalogen group than in the placebo group. There were no between-group differences in physical and laboratory measurements.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    It is suggested that orally administered plasmalogens alleviate negative mood states and sleep problems, and also enhance mental concentration.\n                  <\/jats:p>","DOI":"10.3389\/fcell.2022.894734","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T17:57:17Z","timestamp":1654192637000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Orally Administered Plasmalogens Alleviate Negative Mood States and Enhance Mental Concentration: A Randomized, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.3389","volume":"10","author":[{"given":"Minoru","family":"Fujino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Isogai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Ogaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Wakana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.nut.2007.12.002","article-title":"Effects of Oral Administration of Caffeine and D-Ribose on Mental Fatigue","volume":"24","author":"Ataka","year":"2008","journal-title":"Nutrition"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1519\/jsc.0000000000001551","article-title":"Perceived Sleep Quality, Mood States, and Their Relationship with Performance Among Brazilian Elite Athletes During a Competitive Period","volume":"31","author":"Brandt","year":"2017","journal-title":"J. Strength Cond. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.bbadis.2012.05.008","article-title":"Functions of Plasmalogen Lipids in Health and Disease","volume":"1822","author":"Braverman","year":"2012","journal-title":"Biochimica Biophysica Acta (BBA) - Mol. Basis Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/1873-3468.12788","article-title":"From Peroxisomal Disorders to Common Neurodegenerative Diseases - the Role of Ether Phospholipids in the Nervous System","volume":"591","author":"Dorninger","year":"2017","journal-title":"FEBS Lett."},{"key":"B5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1177\/107385840100700308","article-title":"Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia","volume":"7","author":"Farooqui","year":"2001","journal-title":"Neuroscientist"},{"key":"B6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-q","article-title":"Variance Imputation for Overviews of Clinical Trials with Continuous Response","volume":"45","author":"Follmann","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-3-030-60204-8_14","article-title":"Therapeutic Efficacy of Plasmalogens for Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer's Disease","volume":"1299","author":"Fujino","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4172\/2161-0460.1000419","article-title":"Effects of Plasmalogen on Patients with Mild Cognitive Impairment: A Randomized, Placebo-Controlled Trial in Japan","volume":"8","author":"Fujino","year":"2018","journal-title":"J. Alzheimers Dis. Park."},{"key":"B9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ebiom.2017.02.012","article-title":"Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial","volume":"17","author":"Fujino","year":"2017","journal-title":"EBioMedicine"},{"key":"B10","first-page":"474","article-title":"Effects of Plasmalogen on Patients with Moderate-To-Severe Alzheimer\u2019s Disease and Blood Plasmalogen Changes: A Multi-Center, Open-Label Study","volume":"9","author":"Fujino","year":"2019","journal-title":"J. Alzheimer\u2019s Dis. Park."},{"key":"B11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0006-8993(95)00931-f","article-title":"Disease and Anatomic Specificity of Ethanolamine Plasmalogen Deficiency in Alzheimer's Disease Brain","volume":"698","author":"Ginsberg","year":"1995","journal-title":"Brain Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1194\/jlr.P700023-JLR200","article-title":"Peripheral Ethanolamine Plasmalogen Deficiency: A Logical Causative Factor in Alzheimer's Disease and Dementia","volume":"48","author":"Goodenowe","year":"2007","journal-title":"J. Lipid Res."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.815320","article-title":"Plasmalogens Eliminate Aging-Associated Synaptic Defects and Microglia-Mediated Neuroinflammation in Mice","volume":"9","author":"Gu","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/00005072-199907000-00008","article-title":"Decrease and Structural Modifications of Phosphatidylethanolamine Plasmalogen in the Brain with Alzheimer Disease","volume":"58","author":"Guan","year":"1999","journal-title":"J. Neuropathology Exp. Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1046\/j.1471-4159.2001.00332.x","article-title":"Plasmalogen Deficiency in Early Alzheimer's Disease Subjects and in Animal Models: Molecular Characterization Using Electrospray Ionization Mass Spectrometry","volume":"77","author":"Han","year":"2001","journal-title":"J. Neurochem."},{"key":"B16","volume-title":"Profile of Mood States 2","author":"Heuchert","year":"2012"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e83508","DOI":"10.1371\/journal.pone.0083508","article-title":"Plasmalogens Rescue Neuronal Cell Death Through an Activation of Akt and Erk Survival Signaling","volume":"8","author":"Hossain","year":"2013","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"828282","DOI":"10.3389\/fcell.2022.828282","article-title":"Plasmalogens, the Vinyl Ether-Linked Glycerophospholipids, Enhance Learning and Memory by Regulating Brain-Derived Neurotrophic Factor","volume":"10","author":"Hossain","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.bbrc.2018.01.078","article-title":"Oral Ingestion of Plasmalogens Can Attenuate the Lps-Induced Memory Loss and Microglial Activation","volume":"496","author":"Hossain","year":"2018","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1742-2094-9-197","article-title":"Anti-Inflammatory\/Anti-Amyloidogenic Effects of Plasmalogens in Lipopolysaccharide-Induced Neuroinflammation in Adult Mice","volume":"9","author":"Ifuku","year":"2012","journal-title":"J. Neuroinflammation."},{"key":"B21","first-page":"1","article-title":"The Effectiveness of Group Acceptance and Commitment Therapy on Mental Health Among College Students: A Non-Randomized Pilot Trial","volume":"45","author":"Irie","year":"2019","journal-title":"Jpn. J. Assoc. Behav. Cogn. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/09637486.2016.1144719","article-title":"A Randomized, Double Blind, Placebo Controlled Study of Spirulina Supplementation on Indices of Mental and Physical Fatigue in Men","volume":"67","author":"Johnson","year":"2016","journal-title":"Int. J. Food Sci. Nutr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4992\/jjpsy.33.98","article-title":"Studies on the Work Curve of Uchida-Kraepelin","volume":"33","author":"Kashiwagi","year":"1962","journal-title":"Shinrigaku Kenkyu Jpn. J. Psychol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1749-6632.2012.06641.x","article-title":"Effects of Plasmalogens on Systemic Lipopolysaccharide-Induced Glial Activation and \u03b2-Amyloid Accumulation in Adult Mice","volume":"1262","author":"Katafuchi","year":"2012","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B25","first-page":"1","article-title":"The Effectiveness of a Stress Management-Empowerment Program for Psychiatric Nurses: A Randomized Controlled Trial","volume":"22","author":"Katsuki","year":"2013","journal-title":"J. Jpn. Acad. Psychiatr. Ment. Helath Nurs."},{"key":"B26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3233\/JAD-2011-111163","article-title":"Potential Roles of Peroxisomes in Alzheimer's Disease and in Dementia of the Alzheimer's Type","volume":"29","author":"Lizard","year":"2012","journal-title":"Jad"},{"key":"B27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.5665\/sleep.1132","article-title":"The Effects of Sleep Extension on the Athletic Performance of Collegiate Basketball Players","volume":"34","author":"Mah","year":"2011","journal-title":"Sleep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2131\/jts.35.721","article-title":"Early Changes to Oxidative Stress Levels Following Exposure to Formaldehyde in Icr Mice","volume":"35","author":"Matsuoka","year":"2010","journal-title":"J. Toxicol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s11745-016-4170-9","article-title":"Measurement of Ether Phospholipids in Human Plasma with HPLC-ELSD and LC\/ESI-MS After Hydrolysis of Plasma with Phospholipase A1","volume":"51","author":"Mawatari","year":"2016","journal-title":"Lipids"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2671070","article-title":"Improvement of Blood Plasmalogens and Clinical Symptoms in Parkinson's Disease by Oral Administration of Ether Phospholipids: A Preliminary Report","volume":"2020","author":"Mawatari","year":"2020","journal-title":"Parkinson's Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ab.2007.05.020","article-title":"Separation of Intact Plasmalogens and All Other Phospholipids by a Single Run of High-Performance Liquid Chromatography","volume":"370","author":"Mawatari","year":"2007","journal-title":"Anal. Biochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1271\/bbb.90455","article-title":"Simultaneous Preparation of Purified Plasmalogens and Sphingomyelin in Human Erythrocytes with Phospholipase A1 from Aspergillus Orizae","volume":"73","author":"Mawatari","year":"2009","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B33","unstructured":"Manual for the New Physical Fitness Tests (Age of 20-64 Years)1999"},{"key":"B34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/pcn.12073","article-title":"Development and Validation of the Japanese Version of the Athens Insomnia Scale","volume":"67","author":"Okajima","year":"2013","journal-title":"Psychiatry Clin. Neurosci."},{"key":"B35","first-page":"1425","article-title":"The Ameliorative Effect of the Oligomerized-Polyphenol from Litchi Chinensis Fruit Extract (Oplfe) on Temporary Physical Fatigue for University Track and Field Athletes","volume":"46","author":"Okuyama","year":"2018","journal-title":"Jpn. Pharmacol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000341603","article-title":"Changes in Phospholipid Composition of Erythrocyte Membrane in Alzheimer's Disease","volume":"2","author":"Oma","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"key":"B37","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/nu10050574","article-title":"Relationship of a Special Acidified Milk Protein Drink with Cognitive Performance: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Young Adults","volume":"10","author":"Saito","year":"2018","journal-title":"Nutrients"},{"key":"B38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4992\/jjpsy.42.152","article-title":"A Basic Study of the Uchida Kraepelin Psychodiagnostic Test: An Effect of Test-Repetitions Upon the Change of the U-K Curve: An Effect of Test-Repetitions Upon the Change of the U-K Curve","volume":"42","author":"Seiwa","year":"1971","journal-title":"Jpn. J. Psychol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/s0022-3999(00)00095-7","article-title":"Athens Insomnia Scale: Validation of an Instrument Based on Icd-10 Criteria","volume":"48","author":"Soldatos","year":"2000","journal-title":"J. Psychosomatic Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12944-019-1044-1","article-title":"Plasmalogens and Alzheimer's Disease: A Review","volume":"18","author":"Su","year":"2019","journal-title":"Lipids Health Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1751-0759-3-5","article-title":"The Effectiveness of the Uchida-Kraepelin Test for Psychological Stress: An Analysis of Plasma and Salivary Stress Substances","volume":"3","author":"Sugimoto","year":"2009","journal-title":"Biopsychosoc. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3177\/jnsv.62.198","article-title":"Effect of Enzyme-Treated Asparagus Extract (Etas) on Psychological Stress in Healthy Individuals","volume":"62","author":"Takanari","year":"2016","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/antiox9080645","article-title":"Co-Administration of Iron and a Bioavailable Curcumin Supplement Increases Serum Bdnf Levels in Healthy Adults","volume":"9","author":"Tiekou Lorinczova","year":"2020","journal-title":"Antioxidants"},{"key":"B44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bandc.2018.03.011","article-title":"Effect of Meditation on Psychological Distress and Brain Functioning: A Randomized Controlled Study","volume":"125","author":"Travis","year":"2018","journal-title":"Brain Cognition"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25010202","article-title":"8-Oxo-7,2028-Oxo-7,8-Dihydro-2\u2032-Deoxyguanosine (8-OxodG) and 8-Hydroxy-2\u2032-Deoxyguanosine (8-OHdG) as a Potential Biomarker for Gestational Diabetes Mellitus (GDM) Development","volume":"25","author":"Urbaniak","year":"2020","journal-title":"Molecules"},{"key":"B46","unstructured":"Common Terminology Criteria for Adverse Events (Ctcae) Version 5.0 Published."},{"key":"B47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/10590500902885684","article-title":"8-Hydroxy-2\u2032-Deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis","volume":"27","author":"Valavanidis","year":"2009","journal-title":"J. Environ. Sci. Health, Part C"},{"key":"B48","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jsams.2020.12.003","article-title":"The Effect of Mental Fatigue on the Performance of Australian Football Specific Skills Amongst Amateur Athletes","volume":"24","author":"Weerakkody","year":"2021","journal-title":"J. Sci. Med. Sport"},{"key":"B49","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1017\/neu.2015.18","article-title":"Non-Targeted Lipidomics of Csf and Frontal Cortex Grey and White Matter in Control, Mild Cognitive Impairment, and Alzheimer's Disease Subjects","volume":"27","author":"Wood","year":"2015","journal-title":"Acta Neuropsychiatr."},{"key":"B50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1503\/jpn.090059","article-title":"Circulating Plasmalogen Levels and Alzheimer Disease Assessment Scale-Cognitive Scores in Alzheimer Patients","volume":"35","author":"Wood","year":"2010","journal-title":"Jpn"},{"key":"B51","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3233\/jad-150640","article-title":"Alterations in the Levels of Amyloid-\u03b2, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions Between Amyloid-\u03b2 and These Lipids","volume":"50","author":"Yamashita","year":"2015","journal-title":"Jad"},{"key":"B52","volume-title":"Translation Supervisor, Profile of Mood States Second Edition Poms2, Manual of Japanese Version","author":"Yokoyama","year":"2015"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40101-018-0163-0","article-title":"Black Tea Aroma Inhibited Increase of Salivary Chromogranin-A After Arithmetic Tasks","volume":"37","author":"Yoto","year":"2018","journal-title":"J. Physiol. Anthropol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/1567205014666170505101426","article-title":"Lipid Biomarkers in Alzheimer's Disease","volume":"15","author":"Zarrouk","year":"2018","journal-title":"Car"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.894734\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T17:57:26Z","timestamp":1654192646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.894734\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":54,"alternative-id":["10.3389\/fcell.2022.894734"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.894734","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"article-number":"894734"}}